These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 27487572)

  • 21. Report on outcomes of hypomethylating therapy for analyzing prognostic value of Revised International Prognostic Scoring System for patients with lower-risk myelodysplastic syndromes.
    Lee YJ; Park SW; Lee IH; Ahn JS; Kim HJ; Chung JS; Shin HJ; Lee WS; Lee SM; Joo YD; Kim H; Lee HS; Kim YS; Cho YY; Moon JH; Sohn SK
    Ann Hematol; 2016 Oct; 95(11):1795-804. PubMed ID: 27530461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of Patients With Therapy-Related MDS After Chemoimmunotherapy for Chronic Lymphocytic Leukemia Compared With Patients With De Novo MDS: A Single-Institution Experience.
    Cooper JP; Khajaviyan S; Smith SD; Maloney DG; Shustov AR; Warren EH; Soma LA; Lynch RC; Ujjani C; Till B; Halpern AB; Gopal AK; Deeg HJ; Scott BL; Shadman M
    Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):390-395. PubMed ID: 30948330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acquisition of cytogenetic abnormalities in patients with IPSS defined lower-risk myelodysplastic syndrome is associated with poor prognosis and transformation to acute myelogenous leukemia.
    Jabbour E; Takahashi K; Wang X; Cornelison AM; Abruzzo L; Kadia T; Borthakur G; Estrov Z; O'Brien S; Mallo M; Wierda W; Pierce S; Wei Y; Sole F; Chen R; Kantarjian H; Garcia-Manero G
    Am J Hematol; 2013 Oct; 88(10):831-7. PubMed ID: 23760779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular International Prognostic Scoring System for Myelodysplastic Syndromes.
    Bernard E; Tuechler H; Greenberg PL; Hasserjian RP; Arango Ossa JE; Nannya Y; Devlin SM; Creignou M; Pinel P; Monnier L; Gundem G; Medina-Martinez JS; Domenico D; Jädersten M; Germing U; Sanz G; van de Loosdrecht AA; Kosmider O; Follo MY; Thol F; Zamora L; Pinheiro RF; Pellagatti A; Elias HK; Haase D; Ganster C; Ades L; Tobiasson M; Palomo L; Della Porta MG; Takaori-Kondo A; Ishikawa T; Chiba S; Kasahara S; Miyazaki Y; Viale A; Huberman K; Fenaux P; Belickova M; Savona MR; Klimek VM; Santos FPS; Boultwood J; Kotsianidis I; Santini V; Solé F; Platzbecker U; Heuser M; Valent P; Ohyashiki K; Finelli C; Voso MT; Shih LY; Fontenay M; Jansen JH; Cervera J; Gattermann N; Ebert BL; Bejar R; Malcovati L; Cazzola M; Ogawa S; Hellström-Lindberg E; Papaemmanuil E
    NEJM Evid; 2022 Jul; 1(7):EVIDoa2200008. PubMed ID: 38319256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific abnormalities versus number of abnormalities and cytogenetic scoring systems for outcome prediction after allogeneic hematopoietic SCT for myelodysplastic syndromes.
    Kelaidi C; Tzannou I; Baltadakis I; Batsis I; Mallouri D; Spyridonidis A; Gigantes S; Tsirigotis P; Apostolidis I; Athanasiadou A; Manola K; Anagnostopoulos A; Harhalakis N; Sakellari I; Karakasis D
    Bone Marrow Transplant; 2014 Aug; 49(8):1022-8. PubMed ID: 24797183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic analysis of refractory anaemia in adult myelodysplastic syndromes.
    Wang XQ; Chen ZX; Chen SC; Lin GW; Ji MR; Liang JY; Liu DD; Li DG; Ma Y
    Chin Med J (Engl); 2008 Sep; 121(18):1787-91. PubMed ID: 19080358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late effect of atomic bomb radiation on myeloid disorders: leukemia and myelodysplastic syndromes.
    Tsushima H; Iwanaga M; Miyazaki Y
    Int J Hematol; 2012 Mar; 95(3):232-8. PubMed ID: 22370711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of the revised international prognostic scoring system (IPSS-R) in patients with lower-risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS (EUMDS) registry.
    de Swart L; Smith A; Johnston TW; Haase D; Droste J; Fenaux P; Symeonidis A; Sanz G; Hellström-Lindberg E; Cermák J; Germing U; Stauder R; Georgescu O; MacKenzie M; Malcovati L; Holm MS; Almeida AM; Mądry K; Slama B; Guerci-Bresler A; Sanhes L; Beyne-Rauzy O; Luño E; Bowen D; de Witte T
    Br J Haematol; 2015 Aug; 170(3):372-83. PubMed ID: 25907546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cytogenetic abnormalities of 50 MDS patients by FISH detection and conventional karyotype analysis].
    Gao DG; Li BT; Zhou LN; Chen H; Zhang B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1190-4. PubMed ID: 24156432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coalesced multicentric analysis of 2,351 patients with myelodysplastic syndromes indicates an underestimation of poor-risk cytogenetics of myelodysplastic syndromes in the international prognostic scoring system.
    Schanz J; Steidl C; Fonatsch C; Pfeilstöcker M; Nösslinger T; Tuechler H; Valent P; Hildebrandt B; Giagounidis A; Aul C; Lübbert M; Stauder R; Krieger O; Garcia-Manero G; Kantarjian H; Germing U; Haase D; Estey E
    J Clin Oncol; 2011 May; 29(15):1963-70. PubMed ID: 21519021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impacts of cytogenetic categories in the Revised International Prognostic Scoring System on the prognosis of primary myelodysplastic syndromes: results of a single-center study.
    Qu S; Xu Z; Zhang Y; Qin T; Zhang T; Cui R; Xiao Z
    Leuk Lymphoma; 2012 May; 53(5):940-6. PubMed ID: 22023524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience.
    Maung SW; Burke C; Hayde J; Walshe J; McDermott R; Desmond R; McHugh J; Enright H
    Hematology; 2017 Jul; 22(6):341-346. PubMed ID: 28196450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Myelodysplastic Syndrome Prognostic Scoring Systems.
    Bektaş Ö; Üner A; Eliaçık E; Uz B; Işık A; Etgül S; Bozkurt S; Haznedaroğlu İC; Göker H; Sayınalp N; Aksu S; Demiroğlu H; Özcebe Oİ; Büyükaşık Y
    Turk J Haematol; 2016 Jun; 33(2):119-26. PubMed ID: 26376664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization and prognostic implication of 17 chromosome abnormalities in myelodysplastic syndrome.
    Sánchez-Castro J; Marco-Betés V; Gómez-Arbonés X; Arenillas L; Valcarcel D; Vallespí T; Costa D; Nomdedeu B; Jimenez MJ; Granada I; Grau J; Ardanaz MT; de la Serna J; Carbonell F; Cervera J; Sierra A; Luño E; Cervero CJ; Falantes J; Calasanz MJ; González-Porrás JR; Bailén A; Amigo ML; Sanz G; Solé F
    Leuk Res; 2013 Jul; 37(7):769-76. PubMed ID: 23639672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Revised international prognostic scoring system for myelodysplastic syndromes.
    Greenberg PL; Tuechler H; Schanz J; Sanz G; Garcia-Manero G; Solé F; Bennett JM; Bowen D; Fenaux P; Dreyfus F; Kantarjian H; Kuendgen A; Levis A; Malcovati L; Cazzola M; Cermak J; Fonatsch C; Le Beau MM; Slovak ML; Krieger O; Luebbert M; Maciejewski J; Magalhaes SM; Miyazaki Y; Pfeilstöcker M; Sekeres M; Sperr WR; Stauder R; Tauro S; Valent P; Vallespi T; van de Loosdrecht AA; Germing U; Haase D
    Blood; 2012 Sep; 120(12):2454-65. PubMed ID: 22740453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dichotomization of the new revised international prognostic scoring system for a better clinical stratification of patients with myelodysplastic syndromes.
    Montoro J; Pomares H; Villacampa G; Merchán B; Molero A; Alonso E; Gallur L; Grau J; Salamero O; Roldán E; Saumell S; Ortega M; Sureda A; Bosch F; Arnan M; Valcárcel D
    Leuk Lymphoma; 2019 Jun; 60(6):1522-1527. PubMed ID: 30499738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing the prognostic value of risk stratifying models for patients with lower-risk myelodysplastic syndromes: Is one model better?
    Zeidan AM; Sekeres MA; Wang XF; Al Ali N; Garcia-Manero G; Steensma DP; Roboz G; Barnard J; Padron E; DeZern A; Maciejewski JP; List AF; Komrokji RS;
    Am J Hematol; 2015 Nov; 90(11):1036-40. PubMed ID: 26284571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic impact of chromosomal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemia patients. A study by the spanish group of myelodysplastic syndromes.
    Nomdedeu M; Calvo X; Pereira A; Carrió A; Solé F; Luño E; Cervera J; Vallespí T; Muñoz C; Gómez C; Arias A; Such E; Sanz G; Grau J; Insunza A; Calasanz MJ; Ardanaz MT; Hernández-Rivas JM; Azaceta G; Álvarez S; Sánchez J; Martín ML; Bargay J; Gómez V; Cervero CJ; Allegue MJ; Collado R; Campo E; Esteve J; Nomdedeu B; Costa D;
    Genes Chromosomes Cancer; 2016 Apr; 55(4):322-7. PubMed ID: 26690722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS).
    Germing U; Hildebrandt B; Pfeilstöcker M; Nösslinger T; Valent P; Fonatsch C; Lübbert M; Haase D; Steidl C; Krieger O; Stauder R; Giagounidis AA; Strupp C; Kündgen A; Mueller T; Haas R; Gattermann N; Aul C
    Leukemia; 2005 Dec; 19(12):2223-31. PubMed ID: 16193087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age and comorbidities deeply impact on clinical outcome of patients with myelodysplastic syndromes.
    Balleari E; Salvetti C; Del Corso L; Filiberti R; Bacigalupo A; Bellodi A; Beltrami G; Bergamaschi M; Berisso G; Calzamiglia T; Carella AM; Cavalleri M; Da Col A; Favorini S; Forni GL; Goretti R; Miglino M; Mitscheuning L; Molinari E; Racchi O; Scudeletti M; Tassara R; Gobbi M; Lemoli R; Clavio M
    Leuk Res; 2015 Aug; 39(8):846-52. PubMed ID: 26145790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.